Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.
- NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.
- NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_assertion evidence source_evidence_literature NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.
- NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_assertion SIO_000772 14607763 NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.
- NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_assertion wasDerivedFrom befree-2016 NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.
- NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_assertion wasGeneratedBy ECO_0000203 NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.
- befree-2016 importedOn "2016-02-19" NP419935.RAu_fPweFgrmOq-LLKry2KyukgOvzZOfmR6a4oMqzzY6E130_provenance.